Antimicrobial resistance: a microbial risk assessment perspective

被引:65
作者
Snary, EL [1 ]
Kelly, LA
Davison, HC
Teale, CJ
Wooldridge, M
机构
[1] Vet Labs Agcy, Ctr Epidemiol & Risk Anal, Weybridge KT15 3NB, Surrey, England
[2] Univ Strathclyde, Dept Stat & Modelling Sci, Glasgow G1 1XH, Lanark, Scotland
[3] Vet Labs Agcy Shrewsbury, Shrewsbury SY1 4HD, Shrops, England
关键词
data; models; uncertainty; targeted research;
D O I
10.1093/jac/dkh182
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The emergence of antimicrobial-resistant microorganisms in both humans and food animals is a growing concern. Debate has centred on links between antimicrobial use in the production of food animals and the emergence of resistant organisms in the human population. Consequently, microbial risk assessment (MRA) is being used to facilitate scientific investigations of the risks related to the food chain, including quantification of uncertainty and prioritization of control strategies. MRA is a scientific tool that can be used to evaluate the level of exposure and the subsequent risk to human health relating to a specific organism or particular type of resistance. This paper reviews the recent applications of MRA in the area of antimicrobial resistance, and in particular, it focuses on the methods, assumptions and data limitations. Since MRA outputs are dependent on the quality of data inputs used in their development, we aim to promote the generation of good quality data by describing the properties that data should ideally possess for MRA and by highlighting the benefit of data generation specifically for inclusion in MRAs.
引用
收藏
页码:906 / 917
页数:12
相关论文
共 66 条
[1]   Associations between the use of antimicrobial agents for growth promotion and the occurrence of resistance among Enterococcus faecium from broilers and pigs in Denmark, Finland, and Norway [J].
Aarestrup, FM ;
Kruse, H ;
Tast, E ;
Hammerum, AM ;
Jensen, LB .
MICROBIAL DRUG RESISTANCE, 2000, 6 (01) :63-70
[2]   Avoparcin and virginiamycin as animal growth promoters: a plea for science in decision-making [J].
Acar, J ;
Casewell, M ;
Freeman, J ;
Friis, C ;
Goossens, H .
CLINICAL MICROBIOLOGY AND INFECTION, 2000, 6 (09) :477-482
[3]  
*ACMSF, 1999, MICR ANT RES REL FOO
[4]   Risk assessment of the impact on human health of resistant Campylobacter jejuni from fluoroquinolone use in beef cattle [J].
Anderson, SA ;
Woo, RWY ;
Crawford, LM .
FOOD CONTROL, 2001, 12 (01) :13-25
[5]   Glycopeptide resistance in Enterococcus faecium from broilers and pigs following discontinued use of avoparcin [J].
Bager, F ;
Aarestrup, FM ;
Madsen, M ;
Wegener, HC .
MICROBIAL DRUG RESISTANCE, 1999, 5 (01) :53-56
[6]   Indications of in vivo transfer of an epidemic R plasmid from Salmonella enteritidis to Escherichia coli of the normal human gut flora [J].
Balis, E ;
Vatopoulos, AC ;
Kanelopoulou, M ;
Mainas, E ;
Hatzoudis, G ;
Kontogianni, V ;
MalamouLada, H ;
KitsouKiriakopoulou, S ;
Kalapothaki, V .
JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (04) :977-979
[7]   Within-sample and between-sample variation of antimicrobial resistance in fecal Escherichia coli isolates from pigs [J].
Brun, E ;
Holstad, G ;
Kruse, H ;
Jarp, J .
MICROBIAL DRUG RESISTANCE-MECHANISMS EPIDEMIOLOGY AND DISEASE, 2002, 8 (04) :385-391
[8]   Microbial risk assessment: dose-response relations and risk characterization [J].
Buchanan, RL ;
Smith, JL ;
Long, W .
INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY, 2000, 58 (03) :159-172
[9]  
Burch D. G. S., 2002, Pig Journal, V50, P53
[10]   An assessment of the impact of antibiotic resistance in different bacterial species and of the contribution of animal sources to resistance in human infections [J].
Bywater, RJ ;
Casewell, MW .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 (04) :643-645